Proatherogenic Mechanisms in Subclinical Hypothyroidism: Hepatic Lipase Activity in Relation to the VLDL Remnant IDL

Thyroid ◽  
2008 ◽  
Vol 18 (11) ◽  
pp. 1233-1236 ◽  
Author(s):  
Gabriela Brenta ◽  
Gabriela Berg ◽  
Valeria Zago ◽  
Maria Luz Muzzio ◽  
Marta Schnitman ◽  
...  
Keyword(s):  
Lipase Activity ◽  
Subclinical Hypothyroidism ◽  
Hepatic Lipase ◽  
Hepatic Lipase Activity ◽  
Vldl Remnant

scholarly journals Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine

Thyroid ◽  
2016 ◽  
Vol 26 (3) ◽  
pp. 365-372 ◽  
Author(s):  
Gabriela Brenta ◽  
Gabriela Berg ◽  
Veronica Miksztowicz ◽  
Graciela Lopez ◽  
Diego Lucero ◽  
...  
Keyword(s):  
Lipase Activity ◽  
Subclinical Hypothyroidism ◽  
Hepatic Lipase ◽  
Hepatic Lipase Activity ◽  
Activity Response ◽  
Replacement Treatment

Lipoprotein Alterations, Hepatic Lipase Activity, and Insulin Sensitivity in Subclinical Hypothyroidism: Response to L-T4Treatment

Thyroid ◽  
2007 ◽  
Vol 17 (5) ◽  
pp. 453-460 ◽  
Author(s):  
Gabriela Brenta ◽  
Gabriela Berg ◽  
Pablo Arias ◽  
Valeria Zago ◽  
Marta Schnitman ◽  
...  
Keyword(s):  
Insulin Sensitivity ◽  
Lipase Activity ◽  
Subclinical Hypothyroidism ◽  
Hepatic Lipase ◽  
Hepatic Lipase Activity

scholarly journals Infusion of atherogenic lipoprotein particles increases hepatic lipase activity in the rabbit.

1993 ◽  
Vol 34 (1) ◽  
pp. 89-94
Author(s):  
DL Ebert ◽  
RJ Warren ◽  
PJ Barter ◽  
A Mitchell
Keyword(s):  
Lipase Activity ◽  
Hepatic Lipase ◽  
Hepatic Lipase Activity ◽  
Lipoprotein Particles ◽  
Atherogenic Lipoprotein

scholarly journals Metabolic Consequences of Hypoxia from Birth and Dexamethasone Treatment in the Neonatal Rat: Comprehensive Hepatic Lipid and Fatty Acid Profiling

Endocrinology ◽  
2004 ◽  
Vol 145 (11) ◽  
pp. 5364-5372 ◽  
Author(s):  
Eric D. Bruder ◽  
Ping C. Lee ◽  
Hershel Raff
Keyword(s):  
Fatty Acid ◽  
Lipase Activity ◽  
Plasma Glucose ◽  
Plasma Lipids ◽  
Hepatic Lipase ◽  
Neonatal Rat ◽  
Significant Finding ◽  
Dexamethasone Treatment ◽  
Hepatic Lipase Activity ◽  
Hepatic Lipid

Abstract Neonatal hypoxia is a common condition resulting from pulmonary and/or cardiac dysfunction. Dexamethasone therapy is a common treatment for many causes of neonatal distress, including hypoxia. The present study examined the effects of dexamethasone treatment on both normoxic and hypoxic neonatal rats. We performed comprehensive hepatic fatty acid/lipid profiling and evaluated changes in pertinent plasma hormones and lipids and a functional hepatic correlate, i.e. hepatic lipase activity. Rats were exposed to hypoxia from birth to 7 d of age. A 4-d tapering dose regimen of dexamethasone was administered on: postnatal day (PD)3 (0.5 mg/kg), PD4 (0.25 mg/kg), PD5 (0.125 mg/kg), and PD6 (0.05 mg/kg). The most significant finding was that dexamethasone attenuated nearly all hypoxia-induced changes in hepatic lipid profiles. Hypoxia increased the concentration of hepatic triacylglyceride and free fatty acids and, more specifically, increased a number of fatty acid metabolites within these lipid classes. Administration of dexamethasone blocked these increases. Hypoxia alone increased the plasma concentration of cholesterol and triacylglyceride, had no effect on plasma glucose, and only tended to increase plasma insulin. Dexamethasone administration to hypoxic pups resulted in an additional increase in plasma lipid concentrations, an increase in insulin, and a decrease in plasma glucose. Hypoxia and dexamethasone treatment each decreased total hepatic lipase activity. Normoxic pups treated with dexamethasone displayed increased plasma lipids and insulin. The effects of dexamethasone on hepatic function in the hypoxic neonate are dramatic and have significant implications in the assessment and treatment of metabolic dysfunction in the newborn.

scholarly journals Interactions of dietary fat intake and the hepatic lipase –480C→T polymorphism in determining hepatic lipase activity: the Hoorn Study

2005 ◽  
Vol 81 (4) ◽  
pp. 911-915 ◽  
Author(s):  
Griët Bos ◽  
Jacqueline M Dekker ◽  
Edith JM Feskens ◽  
Marga C Ocke ◽  
Giel Nijpels ◽  
...  
Keyword(s):  
Lipase Activity ◽  
Dietary Fat ◽  
Hepatic Lipase ◽  
Fat Intake ◽  
Hepatic Lipase Activity ◽  
Dietary Fat Intake

Variability in Postheparin Hepatic Lipase Activity Is Associated with Plasma Adiponectin Levels in African Americans

2007 ◽  
Vol 55 (4) ◽  
pp. 187-194 ◽  
Author(s):  
Jacob J. Clarenbach ◽  
Gloria Lena Vega ◽  
Beverley Adams-Huet ◽  
Robert V. Considine ◽  
Madia Ricks ◽  
...  
Keyword(s):  
African Americans ◽  
Lipase Activity ◽  
Hepatic Lipase ◽  
Plasma Adiponectin ◽  
Hepatic Lipase Activity

Effects of steroid hormones on rat hepatic lipase activity

1994 ◽  
Vol 109 (1-2) ◽  
pp. 61
Author(s):  
A. Mitchell ◽  
P.L. Griffiths ◽  
N.H. Fidge
Keyword(s):  
Steroid Hormones ◽  
Lipase Activity ◽  
Hepatic Lipase ◽  
Hepatic Lipase Activity

scholarly journals Vanadate-Stimulated Release of Hepatic Lipase Activity from Liver.

1991 ◽  
Vol 39 (12) ◽  
pp. 3287-3289 ◽  
Author(s):  
Tetsuo MORITA ◽  
Fuminori MIKAMI ◽  
Asako KANAGAWA ◽  
Misaki SERA ◽  
Hiroshi UEKI
Keyword(s):  
Lipase Activity ◽  
Hepatic Lipase ◽  
Hepatic Lipase Activity

scholarly journals Atorvastatin Dose-Dependently Decreases Hepatic Lipase Activity in Type 2 Diabetes: Effect of sex and the LIPC promoter variant

Diabetes Care ◽  
2003 ◽  
Vol 26 (2) ◽  
pp. 427-432 ◽  
Author(s):  
I. I.L. Berk-Planken ◽  
N. Hoogerbrugge ◽  
R. P. Stolk ◽  
A. H. Bootsma ◽  
H. Jansen
Keyword(s):  
Type 2 Diabetes ◽  
Lipase Activity ◽  
Hepatic Lipase ◽  
Hepatic Lipase Activity
Sign in / Sign up

Export Citation Format

Share Document